pre-update Archives

On-Demand Webinar

Clinical Pharmacology & Model-Informed Drug Development Insights for Targeted Radiation Therapies

Targeted radiation therapies (TRT) deliver cytotoxic radiation selectively to tumors. In recent years, oncology drug…

CertaraMay 22, 2024

Press Release

Certara Appoints New Chief Human Resources Officer & General Counsel

RADNOR, PA – May 21, 2024 – Certara, Inc. (Nasdaq: CERT), a global leader in…

CertaraMay 21, 2024

Press Coverage

Accelerating the Progress of Kinase Inhibitors in Oncology

The potential of PBPK modeling in answering key questions around these drugs. Hannah Jones, PhDMasoud…

CertaraMay 20, 2024

On-Demand Webinar

Unlocking Efficiency in Formulation Development and Approvals with MIFD & Simcyp Biopharmaceutics [APAC Webinar]

Biopharmaceutical professionals can gain a significant edge in formulation development by attending this free webinar…

CertaraMay 16, 2024

Blog

Reflections on the New FDA Clinical Pharmacology Guidance for Antibody-Drug Conjugates

In recent years, oncology drug developers have invested in antibody-drug conjugates (ADCs). These targeted therapies…

CertaraMay 10, 2024

Announcement

CERTARA & CLOUDSCIENTIFIC ACCELERATE AI FOR DRUG DEVELOPMENT IN CHINA

Partnership will provide biopharmaceutical companies with advanced tools and solutions needed to expedite research …

CertaraMay 10, 2024

Fact Sheet

Accelerate your drug discovery research with D360 and Design Hub

CertaraMay 10, 2024

Live Events

CERTAINTY – Japan

GREATER CERTAINTY IN DRUG DEVELOPMENT Certainty by Certara offers exclusive access to industry leaders and clinical…

CertaraMay 7, 2024

Live Events

CERTAINTY – China

GREATER CERTAINTY IN DRUG DEVELOPMENT Certainty by Certara offers exclusive access to industry leaders and clinical researchers…

CertaraMay 7, 2024

Live Events

CERTAINTY – South Korea

GREATER CERTAINTY IN DRUG DEVELOPMENT Certainty by Certara offers exclusive access to industry leaders and clinical…

CertaraMay 7, 2024

pre-update

Clinical Pharmacology & Model-Informed Drug Development Insights for Targeted Radiation Therapies

Certara Appoints New Chief Human Resources Officer & General Counsel

Accelerating the Progress of Kinase Inhibitors in Oncology

Unlocking Efficiency in Formulation Development and Approvals with MIFD & Simcyp Biopharmaceutics [APAC Webinar]

Reflections on the New FDA Clinical Pharmacology Guidance for Antibody-Drug Conjugates

CERTARA & CLOUDSCIENTIFIC ACCELERATE AI FOR DRUG DEVELOPMENT IN CHINA

Accelerate your drug discovery research with D360 and Design Hub

CERTAINTY – Japan

CERTAINTY – China

CERTAINTY – South Korea

Newsletter sign up

Quick links

Solutions

Contact